Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 1 , Pages 77-90 , March 2006

Testicular dysgenesis syndrome: possible role of endocrine disrupters

References 

  1. Toppari J, Larsen JC, Christiansen P, et al. Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives. 1996;104:741–803
  2. Chilvers C, Pike MC, Forman D, et al. Apparent doubling of frequency of undescended testis in England and Wales in 1962–81. Lancet. 1984;2(8398):330–332
  3. Matlai P, Beral V. Trends in congenital malformations of external genitalia. Lancet. 1985;1(8420):108
  4. Paulozzi LJ, Erickson JD, Jackson RJ. Hypospadias trends in two US surveillance systems. Pediatrics. 1997;100(5):831–834
  5. Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. Environmental Health Perspectives. 1999;107(4):297–302
  6. Toppari J, Kaleva M, Virtanen HE. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Human Reproduction Update. 2001;7(3):282–286
  7. Boisen KA, Kaleva M, Main KM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet. 2004;363(9417):1264–1269
  8. Boisen K, Chellakooty M, Schmidt I, et al. Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at 3 months of age. The Journal of Clinical Endocrinology and Metabolism. 2005;90(7):4041–4046
  9. Adami HO, Bergstrom R, Mohner M, et al. Testicular cancer in nine northern European countries. International Journal of Cancer. 1994;59(1):33–38
  10. Moller H. Trends in sex-ratio, testicular cancer and male reproductive hazards: are they connected?. Acta Pathologica Microbiologica et Immunologica Scandinavica. 1998;106(1):232–238
  11. Richiardi L, Bellocco R, Adami HO, et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiology Biomarkers and Prevention. 2004;13(12):2157–2166
  12. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. British Medical Journal. 1992;305(6854):609–613
  13. Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. The New England Journal of Medicine. 1995;332(5):281–285
  14. Irvine S, Cawood E, Richardson D, et al. Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years. British Medical Journal. 1996;312(7029):467–471
  15. Andersen AG, Jensen TK, Carlsen E, et al. High frequency of sub-optimal semen quality in an unselected population of young men. Human Reproduction. 2000;15(2):366–372
  16. Swan SH, Elkin EP, Fenster L. The question of declining sperm density revisited: an analysis of 101 studies published 1934–1996. Environmental Health Perspectives. 2000;108(10):961–966
  17. Suominen J, Vierula M. Semen quality of finnish men. British Medical Journal. 1993;306(6892):1579
  18. Bujan L, Mansat A, Pontonnier F, Mieusset R. Time series analysis of sperm concentration in fertile men in toulouse, France between 1977 and 1992. British Medical Journal. 1996;312(7029):471–472
  19. Jouannet P, Wang C, Eustache F, et al. Semen quality and male reproductive health: the controversy about human sperm concentration decline. Acta Pathologica Microbiologica et Immunologica Scandinavica. 2001;109(5):333–344
  20. Jorgensen N, Carlsen E, Nermoen I, et al. East–west gradient in semen quality in the Nordic–Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Human Reproduction. 2002;17(8):2199–2208
  21. Giwercman A, Bruun E, Frimodt-Moller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. The Journal of Urology. 1989;142(4):998–1001
  22. Prener A, Engholm G, Jensen OM. Genital anomalies and risk for testicular cancer in danish men. Epidemiology. 1996;7(1):14–19
  23. Moller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case-control study. British Medical Journal. 1999;318(7183):559–562
  24. Weidner IS, Moller H, Jensen TK, Skakkebaek NE. Risk factors for cryptorchidism and hypospadias. The Journal of Urology. 1999;161(5):1606–1609
  25. Batata MA, Chu FC, Hilaris BS, et al. Testicular cancer in cryptorchids. Cancer. 1982;49(5):1023–1030
  26. Rorth M, Rajpert-De Meyts E, Andersson L, et al. Carcinoma in situ in the testis. Scandinavian Journal of Urology and Nephrology Supplementum. 2000;205:166–186
  27. Berthelsen JG, Skakkebaek NE. Testicular cancer: abnormal structure and function of the contralateral testis. International Journal of Andrology. 1983;6(3):209–211
  28. Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. International Journal of Andrology. 1987;10(1):19–28
  29. Jacobsen R, Bostofte E, Engholm G, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. British Medical Journal. 2000;321(7264):789–792
  30. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction. 2001;16(5):972–978
  31. Baskin LS. Hypospadias and urethral development. The Journal of Urology. 2000;163(3):951–956
  32. Toppari J, Kaleva M. Maldecendus testis. Hormone Research. 1999;51:261–269
  33. Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K, et al. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. Acta Pathologica Microbiologica et Immunologica Scandinavica. 1998;106(1):198–204
  34. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Research. 2003;63(9):2244–2250
  35. Almstrup K, Hoei-Hansen CE, Wirkner U, et al. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Research. 2004;64(14):4736–4743
  36. Sharpe RM. The 'oestrogen hypothesis'— where do we stand now?. International Journal of Andrology. 2003;26(1):2–15
  37. Pierik FH, Burdorf A, Deddens JA, et al. Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environmental Health Perspectives. 2004;112(15):1570–1576
  38. Berkowitz GS, Lapinski RH, Godbold JH, et al. Maternal and neonatal risk factors for cryptorchidism. Epidemiology. 1995;6(2):127–131
  39. Francois I, de Zegher F, Spiessens C, et al. Low birth weight and subsequent male subfertility. Pediatric Research. 1997;42(6):899–901
  40. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. The Journal of Pathology. 2003;200(3):370–374
  41. Petersen PM, Skakkebaek NE, Giwercman A. Gonadal function in men with testicular cancer: biological and clinical aspects. Acta Pathologica Microbiologica et Immunologica Scandinavica. 1998;106(1):24–34
  42. Sohval AR. Testicular dysgenesis as an etiologic factor in cryptorchidism. The Journal of Urology. 1954;72(4):693–702
  43. Huff DS, Hadziselimovic F, Snyder HM, et al. Histologic maldevelopment of unilaterally cryptorchid testes and their descended partners. European Journal of Pediatrics. 1993;152(supplement 2):S11–S14
  44. Pinczowski D, McLaughlin JK, Lackgren G, et al. Occurrence of testicular cancer in patients operated on for cryptorchidism and inguinal hernia. The Journal of Urology. 1991;146(5):1291–1294
  45. Khuri FJ, Hardy BE, Churchill BM. Urologic anomalies associated with hypospadias. The Urologic Clinics of North America. 1981;8(3):565–571
  46. Czeizel A. Increasing trends in congenital malformations of male external genitalia. Lancet. 1985;1(8426):462–463
  47. John Radcliffe Hospital Cryptorchidism Study Group . Cryptorchidism: an apparent substantial increase since 1960. British Medical Journal (Clinical Research Education). 1986;293(6559):1401–1404
  48. Fisch H, Goluboff ET, Olson JH, et al. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertility and Sterility. 1996;65(5):1009–1014
  49. Paulsen CA, Berman NG, Wang C. Data from men in greater seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertility and Sterility. 1996;65(5):1015–1020
  50. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 3rd edn. Cambridge, Cambridge University Press; 1992.
  51. Bonde JP, Kold JT, Brixen LS, et al. Year of birth and sperm count in 10 Danish occupational studies. Scandinavian Journal of Work Environment and Health. 1998;24(5):407–413
  52. Boyle P, Kaye SB, Robertson AG. Changes in testicular cancer in Scotland. European Journal of Cancer Clinical Oncology. 1987;23(6):827–830
  53. McKiernan JM, Goluboff ET, Liberson GL, et al. Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. The Journal of Urology. 1999;162(2):361–363
  54. Bergstrom R, Adami HO, Mohner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. Journal of the National Cancer Institute. 1996;88(11):727–733
  55. Zheng T, Holford TR, Ma Z, et al. Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935–1992. International Journal of Cancer. 1996;65(6):723–729
  56. Hemminki K, Li X. Cancer risks in nordic immigrants and their offspring in Sweden. European Journal of Cancer. 2002;38(18):2428–2434
  57. Spitz MR, Sider JG, Pollack ES, et al. Incidence and descriptive features of testicular cancer among United States whites, blacks, and Hispanics, 1973–1982. Cancer. 1986;58(8):1785–1790
  58. Stat bite: US Incidence of testicular cancer. Journal of the National Cancer Institute; 1999; 91(21):1803.
  59. Henderson BE, Benton B, Jing J, et al. Risk factors for cancer of the testis in young men. International Journal of Cancer. 1979;23(5):598–602
  60. Henderson BE, Bernstein L, Ross RK, et al. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. British Journal of Cancer. 1988;57:216–218
  61. Weir HK, Marrett LD, Kreiger N, et al. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. International Journal of Cancer. 2000;87(3):438–443
  62. Storgaard L, Bonde JP, Olsen J. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reproductive Toxicology; in press.
  63. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. The New England Journal of Medicine. 1971;284(15):878–881
  64. Henderson BE, Benton B, Cosgrove M, et al. Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics. 1976;58(4):505–507
  65. Gill WB, Schumacher GF, Bibbo M, et al. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. The Journal of Urology. 1979;122(1):36–39
  66. Gill WB, Schumacher GF, Bibbo M. Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero. The Journal of Urology. 1977;117(4):477–480
  67. Leary FJ, Resseguie LJ, Kurland LT, et al. Males exposed in utero to diethylstilbestrol. The Journal of the American Medical Association. 1984;252(21):2984–2989
  68. Strohsnitter WC, Noller KL, Hoover RN, et al. Cancer risk in men exposed in utero to diethylstilbestrol. Journal of the National Cancer Institute. 2001;93(7):545–551
  69. Rivas A, Fisher JS, McKinnell C, et al. Induction of reproductive tract developmental abnormalities in the male rat by lowering androgen production or action in combination with a low dose of diethylstilbestrol: evidence for importance of the androgen-estrogen balance. Endocrinology. 2002;143(12):4797–4808
  70. Sharpe RM, Skakkebæk NE. Male reproductive disorders and the role of endocrine disruption: advances in understanding and identification of areas for future research. Pure and Applied Chemistry. 2003;75:2023–2038
  71. Fisher JS, Macpherson S, Marchetti N, Sharpe RM. Human ‘testicular dysgenesis syndrome’: a possible model using in-utero exposure of the rat to dibutyl phthalate. Human Reproduction. 2003;18(7):1383–1394
  72. Mahood IK, Hallmark N, McKinnell C, et al. Abnormal Leydig Cell aggregation in the fetal testis of rats exposed to di (n-butyl) phthalate and its possible role in testicular dysgenesis. Endocrinology. 2005;146(2):613–623
  73. Calafat AM, Slakman AR, Silva MJ, et al. Automated solid phase extraction and quantitative analysis of human milk for 13 phthalate metabolites. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences. 2004;805:49–56
  74. Mortensen GK, Main KM, Andersson A-M, et al. Determination of phthalate monoesters in human breast milk, consumer milk and infant formula by tandem mass spectrometry(LC/MC/MS). Analytical and Bioanalytical Chemistry. 2005;382(4):1084–1092
  75. Sohoni P, Sumpter JP. Several environmental oestrogens are also anti-androgens. The Journal of Endocrinology. 1998;158(3):327–339
  76. Dolk H, Vrijheid M, Armstrong B, et al. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Lancet. 1998;352(9126):423–427
  77. Garcia-Rodriguez J, Garcia-Martin M, Nogueras-Ocana M, et al. Exposure to pesticides and cryptorchidism: geographical evidence of a possible association. Environmental Health Perspectives. 1996;104(10):1090–1095
  78. Weidner IS, Moller H, Jensen TK, Skakkebaek NE. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environmental Health Perspectives. 1998;106(12):793–796
  79. Hardell L, Van Bavel B, Lindstrom G, et al. Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancer. International Journal of Andrology. 2004;27(5):282–290
  80. Hauser R, Chen Z, Pothier L, et al. The relationship between human semen parameters and environmental exposure to polychlorinated biphenyls and p,p'-DDE. Environmental Health Perspectives. 2003;111(12):1505–1511
  81. Swan SH, Kruse RL, Liu F, et al. Semen quality in relation to biomarkers of pesticide exposure. Environmental Health Perspectives. 2003;111(12):1478–1484
  82. Swan SH, Brazil C, Drobnis EZ, et al. Geographic differences in semen quality of fertile US males. Environmental Health Perspectives. 2003;111(4):414–420
  83. Mylchreest E, Wallace DG, Cattley RC, Foster PM. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to Di(n-butyl) phthalate during late gestation. Toxicological Sciences. 2000;55(1):143–151
  84. Swan SH, Main K, Liu C, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives. 2005;113(8):1056–1061
  85. Hoei-Hansen CE, Rajpert-De Meyts E, Carlsen E, et al. Fast-track article: a subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2{gamma} in semen samples: case report. Human Reproduction. 2005;20(3):579–582
  86. Jensen TK, Andersson AM, Jorgensen N, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertility and Sterility. 2004;82(4):863–870
  87. Jensen TK, Jorgensen N, Punab M, et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. American Journal of Epidemiology. 2004;159(1):49–58

PII: S1521-690X(05)00071-0

doi: 10.1016/j.beem.2005.09.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 1 , Pages 77-90 , March 2006

Article Tools

* Image Usage & Resolution